SAM
RIGL icon

Sectoral Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Sectoral Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,861
Closed -$317K – 129
2018
Q3 		$317K Buy
+9,861
New +$296K 0.03% 106

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sectoral Asset Management's RIGL Position: Q4 2018 in Review

Sectoral Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2018, closing a stake of 9,861 shares — an estimated $317K sold.

Sectoral Asset Management first reported a position in RIGL in Q3 2018 and held it in 1 quarter. The position peaked at $317K in Q3 2018. 133 funds tracked by Wall St. Rank hold RIGL as of Q4 2018.

  • Sectoral Asset Management reported no remaining Rigel Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Sectoral Asset Management sold 9,861 Rigel Pharmaceuticals shares in Q4 2018, an estimated $317K.
  • Sectoral Asset Management first reported a position in Rigel Pharmaceuticals in Q3 2018 and held it in 1 quarter.
  • Sectoral Asset Management's Rigel Pharmaceuticals position peaked at $317K in Q3 2018.
  • 133 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2018.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.